Medicare announced that the conditions for lifting the sales restrictions during the first lifting period of the company's 2024 Stock Options and Restricted Stock Incentive Plan have been granted for Class 1 restricted stocks. A total of 46 people were eligible for the incentive to lift the sales restrictions. The number of restricted shares that can be lifted is 918,050,000 shares, accounting for 0.22% of the company's total share capital as of September 3, 2026. The listing and circulation date is September 10, 2026. The grant date for the first class of restricted shares in this incentive plan is September 10, 2025. The grant price is 3.69 yuan/share, and the number of shares granted is 1.874,500 shares. The proportion of shares that can be lifted during the first period when the sales restrictions are lifted is 50%.

Medicare announced that the conditions for lifting the sales restrictions during the first lifting period of the company's 2024 Stock Options and Restricted Stock Incentive Plan have been granted for Class 1 restricted stocks. A total of 46 people were eligible for the incentive to lift the sales restrictions. The number of restricted shares that can be lifted is 918,050,000 shares, accounting for 0.22% of the company's total share capital as of September 3, 2026. The listing and circulation date is September 10, 2026. The grant date for the first class of restricted shares in this incentive plan is September 10, 2025. The grant price is 3.69 yuan/share, and the number of shares granted is 1.874,500 shares. The proportion of shares that can be lifted during the first period when the sales restrictions are lifted is 50%.